- Home
- ALGS vs ZTEK Comparison
ALGS vs ZTEK Comparison
Compare ALGS & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- ZTEK
- Stock Information
- Founded
- ALGS 2018
- ZTEK 2008
- Country
- ALGS United States
- ZTEK Canada
- Employees
- ALGS N/A
- ZTEK N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- ZTEK Major Chemicals
- Sector
- ALGS Health Care
- ZTEK Industrials
- Exchange
- ALGS Nasdaq
- ZTEK Nasdaq
- Market Cap
- ALGS 118.8M
- ZTEK 116.6M
- IPO Year
- ALGS 2020
- ZTEK N/A
- Fundamental
- Price
- ALGS $39.84
- ZTEK $0.86
- Analyst Decision
- ALGS Strong Buy
- ZTEK
- Analyst Count
- ALGS 1
- ZTEK 0
- Target Price
- ALGS $75.00
- ZTEK N/A
- AVG Volume (30 Days)
- ALGS 428.8K
- ZTEK 37.3K
- Earning Date
- ALGS 11-06-2024
- ZTEK 02-11-2025
- Dividend Yield
- ALGS N/A
- ZTEK N/A
- EPS Growth
- ALGS N/A
- ZTEK N/A
- EPS
- ALGS N/A
- ZTEK N/A
- Revenue
- ALGS $5,997,000.00
- ZTEK $29,132.00
- Revenue This Year
- ALGS N/A
- ZTEK N/A
- Revenue Next Year
- ALGS N/A
- ZTEK N/A
- P/E Ratio
- ALGS N/A
- ZTEK N/A
- Revenue Growth
- ALGS N/A
- ZTEK 8.15
- 52 Week Low
- ALGS $6.76
- ZTEK $0.50
- 52 Week High
- ALGS $41.64
- ZTEK $1.59
- Technical
- Relative Strength Index (RSI)
- ALGS 80.76
- ZTEK 34.48
- Support Level
- ALGS $28.00
- ZTEK $1.05
- Resistance Level
- ALGS $35.89
- ZTEK $1.16
- Average True Range (ATR)
- ALGS 4.05
- ZTEK 0.08
- MACD
- ALGS 0.51
- ZTEK -0.04
- Stochastic Oscillator
- ALGS 89.77
- ZTEK 8.57
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.